IMMPORT THERAPEUTICS, INC.

Address

1 Technology Drive, Suite E309
IRVINE, CA, 92618-2343

Information

DUNS: 159838106
# of Employees: N/A

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Development of a Pan-HIV Proteomic Chip

    Amount: $225,000.00

    DESCRIPTION (provided by applicant): HIV-1 causes the largest number of deaths from a single infectious agent in the world today. Despite considerable advances in treatment of HIV-1 infection and AIDS ...

    SBIRPhase I2014Department of Health and Human Services
  2. Protective biomarkers for the development of vaccines against malaria

    Amount: $2,341,413.00

    DESCRIPTION (provided by applicant): For the Phase I SBIR grant we constructed a Plasmodium falciparum (Pf) 3D7 protein microarray containing 2,320 individual polypeptides representing 1,200 known and ...

    SBIRPhase II2012Department of Health and Human Services
  3. Integrated Microfluidic Platform for Point-of-Care Serodiagnostics

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): We aim to develop a fully integrated microfluidic immunodiagnostic platform utilizing a novel air-liquid cavity acoustic transducer (ALCAT) technology pioneered in ...

    SBIRPhase I2012Department of Health and Human Services
  4. Seriodiagnostic arrays for biodefense and emerging infectious diseases

    Amount: $2,991,860.00

    DESCRIPTION (provided by applicant): In Phase I of this SBIR, ImmPORT Therapeutics and the UCI Proteomics Core developed a high throughput gene cloning and protein expression platform that allowed the ...

    SBIRPhase II2008Department of Health and Human Services
  5. Antibodies to malaria blood stages in mixed-species infections

    Amount: $594,009.00

    DESCRIPTION (provided by applicant): Malaria remains one of the most prevalent and lethal human infectious diseases worldwide. Of the four species of malaria parasites that infect humans (Plasmodium f ...

    SBIRPhase I2008Department of Health and Human Services
  6. Development of a multiplex serodiagnostic assay for B burgdorferi infection

    Amount: $525,836.00

    DESCRIPTION (provided by applicant): Lyme disease (LD), the most commonly reported arthropod-borne infection in the United States and Europe, is increasing in its distribution on both continents. The ...

    SBIRPhase I2007Department of Health and Human Services
  7. Scanning Chlamydia proteome for vaccine antigens

    Amount: $300,000.00

    DESCRIPTION (provided by applicant): Throughout the world Chlamydia trachomatis is the most common sexually transmitted bacterial pathogen. In areas with poor sanitary conditions C. trachomatis causes ...

    STTRPhase I2007Department of Health and Human Services
  8. Scanning the P. falciparum proteome for vaccine antigens

    Amount: $598,668.00

    DESCRIPTION (provided by applicant): The abundance of genomic data from infectious microorganisms provides a wealth of information that may now be used to identify antigen targets for subunit vaccine ...

    SBIRPhase I2005Department of Health and Human Services
  9. Adjuvants for Agile Vaccine Development

    Amount: $886,845.00

    DESCRIPTION (provided by applicant): Because of the potential bioterrorism threat, the development of safe and effective vaccines against the infectious microorganisms on the select agents list is a n ...

    SBIRPhase I2005Department of Health and Human Services
  10. Vaccinia Proteome Affinity Reagents From Phage Display

    Amount: $995,030.00

    DESCRIPTION (provided by applicant): The need for nimble technology platforms to counter bioterrorism threats motivates the research proposed here. In this project, reagents with high affinity and sp ...

    SBIRPhase I2004Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government